Table 3. Treatment and clinical outcomes.
| Variables | Total (n=75) | Non-ProLOS (n=50) | ProLOS (n=25) | P value |
|---|---|---|---|---|
| LOS in hospital (days), median [IQR] | 11 [5, 15] | 7 [4, 11] | 16 [15, 17] | <0.001 |
| Cost (RMB), median (IQR) | 7,388.19 (5,085.39, 11,145.44) |
5,855.64 (4,758.35, 8,885.84) |
10,250.85 (9,197.60, 25,316.12) |
<0.001 |
| Antiviral, n [%] | 75 [100] | 50 [100] | 25 [100] | 1.000 |
| Corticosteroids, n [%] | 17 [23] | 8 [16] | 9 [36] | 0.097 |
| Antibiotic, n [%] | 75 [100] | 50 [100] | 25 [100] | 1.000 |
ProLOS, prolonged length of stay in hospital; LOS, length of stay; IQR, interquartile range.